A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT07306182
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 210 participants
- Sponsor
- Beijing Sungen Biomedical Technology Co., Ltd
- Registry
-
NCT07306182
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07306182. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-09 (actual); primary completion 2027-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction
- Condition
- Acute Anterior ST-Segment Elevation Myocardial Infarction
- Intervention (Drug)
- SGC001 injection
- Intervention (Drug)
- SGC001 injection
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing Sungen Biomedical Technology Co., Ltd
Record details
- Record id
cardio:ct-nct07306182- Content hash
140347776ea336f3b0c49f5cb8ed249d57be220d3ab6a8047b9e6737b8c0c24d